Skip to main content
Premium Trial:

Request an Annual Quote

HealthTrust to Offer Nanosphere MDx Tests to Acute Care Facility Members

NEW YORK (GenomeWeb) — Nanosphere said today that it has been selected by HealthTrust to provide multi-target molecular diagnostic tests for nearly 1,400 acute care facilities that are part of the HealthTrust membership.

Under the agreement, HealthTrust's members will have access to purchase Nanosphere's portfolio of Verigene multiplex molecular diagnostics tests for infectious diseases, including assays for detecting infections of the bloodstream, respiratory tract, and gastrointestinal tract.

The agreement went into effect June 1, Northbrook, Ill.-based Nanosphere said.

The Verigene system uses Nanosphere's core proprietary gold nanoparticle chemistry to offer highly sensitive, specific, multiplexed and low-cost molecular diagnostic tests.

HealthTrust, legally known as HealthTrust Purchasing Group, provides cost management services to healthcare businesses. In addition to the approximately 1,400 acute care facilities, the Brentwood, Tenn.-based company serves 800 ambulatory surgery centers and members in more than 10,600 other locations, including physician practices, long-term care, and alternate care sites.

The Scan

Fertility Fraud Found

Consumer genetic testing has uncovered cases of fertility fraud that are leading to lawsuits, according to USA Today.

Ties Between Vigorous Exercise, ALS in Genetically At-Risk People

Regular strenuous exercise could contribute to motor neuron disease development among those already at genetic risk, Sky News reports.

Test Warning

The Guardian writes that the US regulators have warned against using a rapid COVID-19 test that is a key part of mass testing in the UK.

Science Papers Examine Feedback Mechanism Affecting Xist, Continuous Health Monitoring for Precision Medicine

In Science this week: analysis of cis confinement of the X-inactive specific transcript, and more.